Logo image
Dose-response assessment for influenza A virus based on data sets of infection with its live attenuated reassortants
Journal article   Peer reviewed

Dose-response assessment for influenza A virus based on data sets of infection with its live attenuated reassortants

Toru Watanabe, Timothy A Bartrand, Tatsuo Omura and Charles N Haas
Risk analysis, v 32(3), pp 555-565
Mar 2012
PMID: 21977924

Abstract

Influenza Vaccines - administration & dosage Reassortant Viruses - pathogenicity Humans Influenza A virus - genetics Reassortant Viruses - genetics Risk Influenza A Virus, H3N2 Subtype - genetics Virulence - genetics Vaccines, Attenuated - administration & dosage Influenza A virus - pathogenicity Adult Influenza, Human - virology Child Influenza A Virus, H1N1 Subtype - genetics Disease Models, Animal Influenza A Virus, H3N2 Subtype - pathogenicity Influenza A Virus, H1N1 Subtype - pathogenicity Influenza, Human - etiology Models, Statistical Animals Models, Biological Orthomyxoviridae Infections - etiology Influenza A virus - classification Orthomyxoviridae Infections - virology Reassortant Viruses - classification
Reported data sets on infection of volunteers challenged with wild-type influenza A virus at graded doses are few. Alternatively, we aimed at developing a dose-response assessment for this virus based on the data sets for its live attenuated reassortants. Eleven data sets for live attenuated reassortants that were fit to beta-Poisson and exponential dose-response models. Dose-response relationships for those reassortants were characterized by pooling analysis of the data sets with respect to virus subtype (H1N1 or H3N2), attenuation method (cold-adapted or avian-human gene reassortment), and human age (adults or children). Furthermore, by comparing the above data sets to a limited number of reported data sets for wild-type virus, we quantified the degree of attenuation of wild-type virus with gene reassortment and estimated its infectivity. As a result, dose-response relationships of all reassortants were best described by a beta-Poisson model. Virus subtype and human age were significant factors determining the dose-response relationship, whereas attenuation method affected only the relationship of H1N1 virus infection to adults. The data sets for H3N2 wild-type virus could be pooled with those for its reassortants on the assumption that the gene reassortment attenuates wild-type virus by at least 63 times and most likely 1,070 times. Considering this most likely degree of attenuation, 10% infectious dose of H3N2 wild-type virus for adults was estimated at 18 TCID50 (95% CI = 8.8-35 TCID50). The infectivity of wild-type H1N1 virus remains unknown as the data set pooling was unsuccessful.

Metrics

16 Record Views
33 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Mathematics, Interdisciplinary Applications
Public, Environmental & Occupational Health
Social Sciences, Mathematical Methods
Logo image